IE 11 is a very old Browser and it`s not supported on this site
ESG Annex

Annex

GRI content index with reference

GRI content index

 

 

Statement of use

 

BB Biotech AG has reported the information cited in this GRI content index for the period 01.01.2022 – 31.12.2022 with reference to the GRI Standards.

GR1 used

 

GRI 1: Foundation 2021

GRI Standard

 

Dislosure

 

Location in Annual Report

GRI 2: General Disclosures 2021

 

2-1 Organizational details

 

About us

 

 

2-2 Entities included in the organization’s sustainability reporting

 

Sustainability Governance

 

 

2-3 Reporting period, frequency and contact point

 

About us: Corporate calendar / Contact

 

 

2-6 Activities, value chain and other business relationships

 

About us

 

 

2-7 Employees

 

Social Practices

 

 

2-9 Governance structure and composition

 

Corporate Governance

 

 

2-10 Nomination and selection of the highest governance body

 

Corporate Governance: Board of Directors

 

 

2-11 Chair of the highest governance body

 

Corporate Governance: Board of Directors

 

 

2-19 Remuneration policies

 

Remuneration Report: Remuneration of the members of the Board of Directors

 

 

2-20 Process to determine remuneration

 

Remuneration Report: Remuneration of the members of the Board of Directors

 

 

2-22 Statement on sustainable development strategy

 

Sustainability Strategy

 

 

2-25 Processes to remediate negative impacts

 

Environmental practices

 

 

2-26 Mechanisms for seeking advice and raising concerns

 

Social Practices: Diversity and Inclusion

 

 

2-28 Membership associations

 

Environmental practices: Key climate-relevant memberships

 

 

2-29 Approach to stakeholder engagement

 

Stakeholder Engagement and Material ESG Topics

GRI 3: Material Topics 2021

 

3-1 Process to determine material topics

 

Stakeholder Engagement and Material ESG Topics

 

 

3-2 List of material topics

 

Stakeholder Engagement and Material ESG Topics: Material ESG topics identified

 

 

3-3 Management of material topics

 

Stakeholder Engagement and Material ESG Topics: Material ESG topics identified

GRI 201: Economic Performance 2016

 

201-1 Direct economic value generated and distributed

 

Financial report

GRI 302: Energy 2016

 

302-1 Energy consumption within the organization

 

Environmental Practices: Energy consumption

GRI 305: Emissions 2016

 

305-1 Direct (Scope 1) GHG emissions

 

Environmental Practices: Measurement of environmental indicators

 

 

305-2 Energy indirect (Scope 2) GHG emissions

 

Environmental Practices: Measurement of environmental indicators

 

 

305-3 Other indirect (Scope 3) GHG emissions

 

Environmental Practices: Measurement of environmental indicators

 

 

305-4 GHG emissions intensity

 

Environmental Practices: Total emissions at a glance

 

 

305-5 Reduction of GHG emissions

 

Environmental Practices: CO2 emissions

GRI 306: Waste 2020

 

306-1 Waste generation and significant waste-related impacts

 

Environmental Practices: Waste management and recycling

 

 

306-2 Management of significant waste-related impacts

 

Environmental Practices: Waste management and recycling

GRI 401: Employment 2016

 

401-1 New employee hires and employee turnover

 

Social Practices

 

 

401-2 Benefits provided to full-time employees that are not provided to temporary or part-time employees

 

Social Practices: Employee development and retention

GRI 405: Diversity and Equal Opportunity 2016

 

405-1 Diversity of governance bodies and employees

 

Board of Director level: Diversity and inclusion; Social Practices: Diversity and inclusion

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer